Long term disease modification using immunostimulatory oligonucleotides
US8252757B2 · kind B2 · utility
5Cited by
19References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 9, 2007 |
| Grant date | Aug 28, 2012 |
| Priority date | — |
| Expiry date | Nov 7, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/35
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods for treating asthma by using multiple rounds of administration of ISS over a period of time to confer long term disease modification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.